Doxorubicin Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-436

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 67457-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Doxo 10mg 50mg Inj Mylan Figure 02)

A forest plot chart showing hazard ratios with 95% confidence intervals for various clinical trials comparing doxorubicin-based treatment to CMF. Trials listed include NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3, with an overall summary for six studies. The x-axis ranges from 0 to 2, indicating whether doxorubicin is better or worse than CMF.*

FDA Label Image

Fig-2 (Doxo 10mg 50mg Inj Mylan Figure 03)

A forest plot showing hazard ratios with 95% confidence intervals for six clinical trials comparing Doxorubicin-based treatment to CMF. The horizontal axis ranges from 0 to 2, indicating treatment effect where values less than 1 favor Doxorubicin. Each trial is listed on the left, with corresponding data points and confidence intervals plotted. A diamond shape summarizes the combined results for all six studies.*

FDA Label Image

Structure (Image 01)

Chemical structure of Doxorubicin Hydrochloride depicting its molecular arrangement with assigned functional groups and stereochemistry, alongside its molecular formula (C27H29NO11 · HCl) and molecular weight (579.99).*

FDA Label Image

10 mg Carton (Image 02)

Packaging label for Doxorubicin Hydrochloride for Injection, USP, 10 mg/vial, manufactured by Mylan Institutional LLC. The label designates the product as a lyophilized, single-dose vial with a cytotoxic agent caution. Storage instructions, inactive ingredients, and preparation guidelines are included on the label. The label also bears multiple barcodes and batch information placeholders.*

FDA Label Image

50 mg Carton (Image 03)

Packaging label for Doxorubicin Hydrochloride for Injection, USP, 50 mg/vial as a lyophilized powder. Label includes caution for cytotoxic agent and states it is for IV use only. Manufactured for Mylan Institutional LLC. The label also lists inactive ingredients, storage instructions, and warnings. The product is Rx only and supplied in single-dose vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.